Search

everythinglearnresearchcommunity

for

Search:↓

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Pomegranate shows promise for treating various health issues, but more research is needed.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Adipose-derived stem cell secretome is a promising and effective treatment for skin repair.

Autologous fat transfer improves hair growth in scarring alopecia and allows for denser hair transplants.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Dermatologists are crucial in providing personalized care for patients with sex development differences.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.